Founded in April 2025, the company was born from the founders desire to create an innovative platform driven by a clear missionto make high-quality care simple to start and easy to maintain
If affordability is a concern, talk to your doctor about whether a lower-cost option or patient assistance program makes sense for your situation
We ship from BC, Canada ensuring fast & discrete delivery that is 100% guaranteed
Animal studies show potential risks to fetal development, and there is insufficient human data to determine safety
As an investigational triple-agonist, fully understanding its long-term cardiovascular, gastrointestinal, and pancreatic safety profile is essential before it can transition from a research setting to routine clinical practice. Dr
The glucagon-like peptide-1 receptor agonist semaglutide is approved for the treatment of type 2 diabetes and obesity and has an established safety profile